Pernix therapeutics 10k
WebApr 24, 2015 · Contacts. Pernix Therapeutics Holdings, Inc. Investor Relations In-Site Communications Lisa Wilson, 212-452-2793 [email protected] or Media Relations Marianne Lambertson, (800) 793-2145 ext ... WebMar 6, 2013 · Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded, generic and OTC pharmaceutical products. The...
Pernix therapeutics 10k
Did you know?
WebMay 10, 2024 · Pernix Therapeutics Holdings, Inc. (PTX) SEC Filing 8-K Material Event for the period ending Thursday, May 10, 2024. Home. SEC Filings. ... Insider Trades. Manager Portfolios. Notifications. PTX Annual Reports. 10-K Annual Report March 2024 10-K Annual Report March 2024 10-K Annual Report March 2016 10-K Annual Report March 2015 ... WebMar 29, 2012 · Pernix Therapeutics Holdings, Inc. (PTX) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011
WebApr 11, 2024 · Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that it has closed on the sale of its Houston, TX-based manufacturing operations, Pernix Manufacturing, LLC (“PML”) to Woodfield Pharmaceutical LLC (“Woodfield”). As previously announced ... WebFeb 19, 2024 · Pernix Therapeutics Holdings, Inc., a holding company that owns several subsidiaries, including specialty pharmaceutical companies, including Pernix Therapeutics, LLC, a specialty...
http://filings.irdirect.net/data/1024126/000135448815000878/ptx_10k.pdf WebAdditional information about Pernix is available on the Company's website located at www.pernixtx.com. CONTACT: Pernix Therapeutics Holdings, Inc. Joseph T. Schepers, 800-793-2145, ext. 3002 Director, Investor Relations [email protected]
WebNov 9, 2024 · Pernix Therapeutics Holdings, Inc. (PTX) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2024. Home. SEC Filings. Pernix Therapeutics Holdings, Inc. (PTX) ... 10-K Annual Report March 2024 10-K Annual Report March 2016 10-K Annual Report March 2015 ...
WebMay 10, 2024 · Pernix Therapeutics Holdings, Inc. (PTX) SEC Filing 10-Q Quarterly report for the period ending Saturday, March 31, 2024. Home. SEC Filings. Pernix Therapeutics Holdings, Inc. (PTX) ... 10-K Annual Report March 2024 10-K Annual Report March 2016 10-K Annual Report March 2015 ... foxes that live in the desertWebDec 11, 2012 · About Pernix Therapeutics Holdings, Inc. Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded, generic and OTC pharmaceutical products. The Company manages a portfolio of branded and generic products. black tongue disease in dogsWebThis Securities Purchase Agreement (this “Agreement”) is made and entered into as of November 13, 2012 by and among (i) Cypress Pharmaceuticals, Inc., a Mississippi … foxes the kick vinylWebMar 4, 2024 · Pernix Therapeutics is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The company’s pediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper ... black tongue disease in humansWebMar 10, 2016 · Pernix Therapeutics Holdings, Inc. (PTX) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2015 foxes torrentWebPhone Number 800-793-2145. Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded … foxes that look like dogsWebFeb 14, 2024 · Founded in 1996, Pernix Therapeutics is a specialty pharmaceutical company developing and commercializing products for the treatment of central nervous system indications, including pain,... foxes the kick review